Walvax Biotechnology News

Walvax Biotechnology: Notice on the receipt of two patent certificates for inventions by the company and its subsidiaries

May 24 12:00 ET

Walvax Biotechnology: 2023 Annual Equity Distribution Implementation Notice

May 22 12:00 ET

Walvax Biotechnology: Announcement on the completion of cancellation of some repurchased shares and changes in shares

May 20 05:12 ET

Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240518

May 18 05:10 ET

Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240516

May 16 10:26 ET

Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240513

May 13 07:26 ET

Walvax Biotechnology: Announcement on participating in the 2023 Online Group Reception Day for Investors of Listed Companies in Yunnan

May 9 12:00 ET

Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240428

Apr 28 05:31 ET

Watson Biotech: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Directors

Apr 25 12:00 ET

Watson Biotech: Announcement on Changing the Use of Repurchased Shares and Cancelling and Reducing the Company's Registered Capital

Apr 25 12:00 ET

Watson Biotech: Announcement of Resolutions of the 16th Meeting of the Fifth Board of Supervisors

Apr 25 12:00 ET

Watson Biotech: Announcement of Resolutions of the 17th Meeting of the Fifth Board of Directors

Apr 24 12:00 ET

Watson Biotech: Announcement on holding an online briefing on the results for the first quarter of 2024

Apr 24 12:00 ET

Watson Biotech: First Quarter 2024 Report

Apr 24 12:00 ET

Watson Biotech: Prompt Announcement for the Disclosure of the 2024 First Quarter Report

Apr 24 12:00 ET

Watson Biotech: Announcement of Resolutions of the 15th Meeting of the Fifth Board of Supervisors

Apr 24 12:00 ET

Watson Biotech: Announcement on the termination of clinical trials of the recombinant novel coronavirus vaccine (chimpanzee adenovirus vector)

Apr 24 12:00 ET

Watson Biotech: Announcement on Changing the Use of Repurchased Shares and Cancelling and Reducing the Company's Registered Capital and Notifying Creditors

Apr 22 07:55 ET

Watson Biotech: Legal Opinion of Beijing Guofeng Law Firm on the Company's 2023 Annual General Meeting of Shareholders

Apr 19 12:00 ET

Watson Biotech: Announcement of 2023 Annual General Meeting of Shareholders Resolutions

Apr 19 12:00 ET